Archives
-
Panoramic Mapping of Cardiac Structure and Function
2026-10-12
Kowalik and colleagues describe a multimodal imaging platform that registers collagen-sensitive hyperspectral maps with optical measurements of cardiac membrane potential. In a small perfused-rat-heart infarction model, the approach associated infarct and border-zone tissue with distinct action-potential behavior and localized abnormal excitation near infarct borders. The findings support a proof-of-concept for structure–function analysis, but the sample size, ex vivo animal model, surface-only coverage, and limited validation constrain broader interpretation.
-
Trelagliptin, RUNX2, and Evidence Limits
2026-10-12
A 2021 cell-based study links trelagliptin with osteoblastic differentiation through an AMPK-associated RUNX2 signal, but the evidence remains preclinical and model-limited. APExBIO’s Red Blood Cell Lysis Buffer is a separate sample-preparation product and was not identified as part of that study.
-
Metal-Free Carbon Nanozymes for ALP Detection
2026-10-11
Hsieh and colleagues developed a metal-free carbon-dot nanozyme assay in which alkaline phosphatase activity produces a colorimetric turn-on signal by removing pyrophosphate-mediated inhibition. Kinetic analysis identified pyrophosphate as a noncompetitive inhibitor at a binding site distinct from the principal catalytic site, supporting sensitive ALP measurement while highlighting important boundaries for matrix validation.
-
Human SAN-Plexus Assembloids and Pacemaker Maturation
2026-10-10
Zhang and colleagues developed human pluripotent stem cell-derived assembloids that combine sinoatrial node, cardiac plexus, and atrial-like organoids to model neural regulation of pacemaker activity. Integrated electrophysiology, disease-relevant functional analysis, and spatial transcriptomics support a prosaposin–GPR37 signaling program associated with sinoatrial node maturation, while also defining important limits for interpreting this in vitro model.
-
Ceruletide in Pancreatic Function Research
2026-10-09
Ceruletide, also known as Caerulein in many research contexts, is a synthetic cholecystokinin-like peptide used to examine pancreatic secretion, gastrointestinal physiology, and smooth-muscle responses. This overview separates supplier-described properties from findings in a 2026 preclinical study of mesenchymal-stromal-cell extracellular vesicles and MFGE8 nanoparticles in chronic pancreatitis. The study supports a potentially important antifibrotic pathway, but it does not establish that Ceruletide was used, that CCK-receptor signaling drives the reported MFGE8 effects, or that either approach is clinically effective.
-
TCF25, Lysosomal Acidification, and Cell Fate
2026-10-09
Ren et al. identify TCF25 as a nutrient-responsive regulator that connects glucose starvation to V-ATPase-dependent lysosomal acidification, autophagy, and eventual lysosome-dependent cell death. The study provides a mechanistic framework for understanding how lysosomes shift from adaptive energy-supporting organelles to mediators of injury during prolonged metabolic stress, while also highlighting the need for careful validation across models.
-
Imipramine: Evidence, Mechanisms, and Research Limits
2026-10-08
Imipramine is a tricyclic antidepressant with established transporter pharmacology and reported activity in cancer-cell and autophagy models. Current evidence supports research use in glioma cell autophagy research and HL-60 apoptosis assay design, but it does not establish clinical anticancer efficacy or a direct role in fish nodavirus infection.
-
Biomimetic Chromatography and Pulmonary Permeability
2026-10-08
The 2024 Journal of Chromatography A study provides a comparative assessment of immobilised artificial membrane liquid chromatography and liposome electrokinetic capillary chromatography for modelling drug–membrane partitioning and pulmonary permeability. Its findings suggest that LEKC can better reflect lung-permeability relationships when phospholipid and electrostatic interactions matter, while IAM LC offers broader compound coverage and more straightforward high-throughput use.
-
DiscoveryProbe™: From Metabolomics to Mechanism
2026-10-07
Metabolomic signatures can reveal clinically important biology without fully explaining causality. This thought-leadership article examines how the burn-injury study of propranolol connects catecholamine signaling with lipolysis, lipid remodeling, and endoplasmic-reticulum stress, then considers how focused chemical collections can support translational hypothesis testing. It also positions the DiscoveryProbe™ Metabolism-related Compound Library within a broader research landscape while emphasizing evidence boundaries, orthogonal validation, and the difference between mechanistic discovery and clinical proof.
-
HHV-7 DNA in Ocular Toxoplasmosis: Case Evidence
2026-10-07
This 2023 case report documents simultaneous detection of Toxoplasma gondii and human herpesvirus 7 DNA in vitreous fluid from a patient with recurrent, treatment-refractory ocular toxoplasmosis. The finding expands the differential interpretation of chronic infectious uveitis, but the single-case design cannot establish that HHV-7 reactivation caused the refractory disease.
-
Forsythoside E: Evidence and Research Context
2026-10-06
Forsythoside E is a phenolic acid glycoside being investigated as a PKM2-directed immunometabolic compound. Current evidence is primarily supplier-reported and centers on macrophage metabolism, STAT3 signaling, and mouse sepsis-related liver injury, with substantial gaps in independent validation and clinical applicability.
-
Ceramides and Autophagy in RGNNV Infection
2026-10-06
A 2026 Journal of Virology study used lipidomics and complementary perturbation evidence to identify ceramide accumulation as a pro-viral feature of red-spotted grouper nervous necrosis virus infection. The work connects capsid-associated lipid remodeling with autophagy while also showing why the mechanism should not be transferred directly to unrelated viruses, hosts, or therapeutic settings.
-
ATF4 Enhancer Programs in Liver Fibrosis
2026-10-05
A 2025 Nature Communications study identifies a non-canonical ATF4-regulated enhancer program that drives profibrotic gene expression in hepatic stellate cells. The findings connect TGFβ signaling, ATF4-dependent transcription, and fibrosis progression while suggesting a pharmacological route for testing ATF4 translation as a therapeutic vulnerability.
-
Solanesol (B8776): Product Overview
2026-10-05
Solanesol is a vendor-described polyisoprenoid alcohol supplied by APExBIO as SKU B8776. The available evidence covers product identity and broad research scope only; no matched peer-reviewed paper evidence or independent performance validation was supplied.
-
TBK1, Microglial Pyroptosis, and Diabetic Neuropathy
2026-10-04
Liao et al. identify TANK-binding kinase 1 (TBK1) as a signaling driver linking spinal microglial inflammation to painful diabetic neuropathy in mouse models. Their genetic and pharmacological evidence supports TBK1, NF-κB, and NLRP3-associated pyroptosis as a mechanistic axis, while also highlighting the limits of translating preclinical pain findings to human disease.